Target intelligence / Profile preview

Oat protein nanofibril–iron nanoparticle interface (OPN-FeNP interface)

Target
OPN-FeNP interface
Molecular classification
Protein-nanoparticle composite, Amyloid-like fibril, Biomaterial, Other
01

Overview

The oat protein nanofibril–iron nanoparticle interface is a synthetic biomimetic structure developed for the efficient delivery of iron in nutritional and therapeutic applications. It consists of oat-derived protein nanofibrils, which are amyloid-like aggregates that provide a robust scaffold for the attachment and stabilization of iron nanoparticles, typically in the form of ferric oxyhydroxide (Mohammadian et al., 2019). This interface is engineered to prevent the premature oxidation and precipitation of iron, which often leads to poor absorption and unpleasant metallic tastes in conventional supplements. By providing a high density of binding sites, the nanofibrils facilitate a high iron loading capacity while maintaining the solubility of the complex under physiological conditions (Shen et al., 2017). In the context of human health, this system is primarily investigated for its potential to treat iron deficiency anemia by improving the bioavailability of iron in the digestive tract. Although it is not a traditional therapeutic target like a receptor or enzyme, the interface is a key focus of research in nanomedicine and food science for optimizing nutrient delivery.

Other names
Oat protein amyloid-like fibrilsOPN-FeNP complexOat protein isolate-based nanofibrilsIron-nanoparticle-protein interface
02

Mechanism of action

Stabilization of iron nanoparticles via a protein scaffold to enhance gastrointestinal absorption and reduce oxidative reactivity.

03

Biological functions

Nutrient deliveryIron fortificationBioavailability enhancementOther
04

Disease associations

Iron deficiency anemiaOther
05

Safety considerations

Potential allergenicity of oat proteinsLong-term safety of nanoparticle ingestionOxidative stress if iron is released prematurely
06

Interacting drugs

Iron (III) oxyhydroxide

1 more in the full profile.

07

Biomarkers

Serum ferritinHemoglobinTransferrin saturation

Beyond the preview

Go deeper on Oat protein nanofibril–iron nanoparticle interface (OPN-FeNP interface).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Oat protein nanofibril–iron nanoparticle interface (OPN-FeNP interface).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call